Beijing Biostar Pharmaceuticals Co., Ltd. (HKG: 2563)
Hong Kong
· Delayed Price · Currency is HKD 16.16
+0.88 (5.76%)
Jan 3, 2025, 4:08 PM HKT
Beijing Biostar Pharmaceuticals Revenue
In the year 2023, Beijing Biostar Pharmaceuticals had annual revenue of 66.64M CNY with 103.03% growth.
Revenue
66.64M CNY
Revenue Growth
+103.03%
P/S Ratio
77.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.89B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 66.64M | 33.82M | 103.03% |
| Dec 31, 2022 | 32.82M | -38.24M | -53.82% |
| Dec 31, 2021 | 71.06M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tencent Holdings | 712.21B |
| Industrial and Commercial Bank of China | 721.24B |
| Agricultural Bank of China | 626.14B |
| China Mobile | 1,135.55B |
| PetroChina Company | 3,306.44B |
| China Construction Bank | 685.54B |
| Bank of China | 589.02B |
| Alibaba Group Holding | 1,065.49B |